Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Axios Pro Rata

Proscia
By Author Proscia | June 16, 2022

Proscia, a Philadelphia-based provider of digital and computational pathology solutions, raised $37m in Series C funding from Highline Capital Management, Triangle Peak Partners, Alpha Intelligence Capital and insiders Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers and Razor’s Edge Ventures.

Our website uses cookies. By using this site, you agree to its use of cookies.